Andreas Radbruch

from Wikipedia, the free encyclopedia

Andreas Radbruch (born November 3, 1952 ) is a German immunologist . He heads the German Rheumatism Research Center Berlin (DRFZ) and is Professor of Experimental Rheumatology at the Charité University Medicine Berlin.

Life

Andreas Radbruch received his diploma in biology from the University of Bonn in 1976 , and in 1980 he received his doctorate from the University of Cologne . As a research assistant or university assistant , he worked - interrupted by a research stay at the University of Alabama at Birmingham in 1987 - until his habilitation in 1988 at the Institute for Genetics at the University of Cologne. He stayed here initially as a lecturer before receiving a professorship for genetics and immunology at the University of Cologne in 1990 .

Radbruch has been Scientific Director of the German Rheumatism Research Center (DRFZ) in Berlin since 1996 . He has held a professorship for experimental rheumatology at the Humboldt University of Berlin since 1998 .

In 2007/2008 Radbruch was President of the German Society for Rheumatology , 2009/2010 of the German Society for Immunology . As of 2019, Radbruch is President of the European Federation of Immunological Societies (EFIS).

Act

Radbruch's research focuses on autoimmunity , inflammation and immunopathology , the biology of T and B lymphocytes and plasma cells, and the development and molecular imprinting of immunological memory . He has made particular contributions to the development of cytometry and cell sorting , especially with magnetic particles (see Magnetic Cell Separation ). He could also the molecular basis of antibody - class change enlighten lymphocytes B. Radbruch discovered that long-lived memory cells (in particular antibody-producing plasma cells but also T-helper cells , from which the T-memory cells develop) survive in special niches in the bone marrow , from where they can provide both the reinforced immune response in the event of a renewed infection Maintain pathological symptoms of inflammation such as rheumatism or chronic inflammatory bowel diseases .

At the DRFZ, Radbruch promoted interdisciplinary collaboration and cooperation with clinical institutions such as the Charité . Successful commercial spin- offs of the DRFZ such as Miltenyi Biotec or Amaxa (later bought by the Lonza Group ) emerged under his aegis .

Awards (selection)

Web links

Individual evidence

  1. ^ Prize winner (1994) of the Karl Heinz Beckurts Foundation (beckurts-stiftung.de); accessed on November 1, 2014.
  2. Awarding of the Aronson Prize in the UKBF to two outstanding scientists. Press release from February 18, 2000 at the Science Information Service (idw-online.de).
  3. Member entry of Andreas Radbruch at the German Academy of Natural Scientists Leopoldina , accessed on November 1, 2014.
  4. ^ Federal Cross of Merit for Andreas Radbruch. ( Memento from March 3, 2016 in the Internet Archive ) (PDF, 47 kB) Press release from March 12, 2008 at the German Society for Rheumatology (dgrh.de).
  5. ^ Andreas Radbruch at the Berlin-Brandenburg Academy of Sciences (bbaw.de); accessed on November 1, 2014.
  6. German Society for Immunology awards Avery Landsteiner Prize for Immunology to Andreas Radbruch, Director of the German Rheumatism Research Center Berlin at the German Society for Immunology (dgfi.org); accessed on November 1, 2014.
  7. German Society for Immunology awards Avery Landsteiner Prize for Immunology. Press release from September 18, 2014 at Informationsdienst Wissenschaft (idw-online.de); accessed on November 1, 2014.